SHULINLISHULIN LI8595LI, SHULINProfessorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson7777 Knight RdHouston77054-3005TXAuthorship 1658771Authorship 1671792Authorship 1696541Authorship 1700691Authorship 1720501Authorship 1721307Authorship 1721521Authorship 1721666Authorship 1733061Authorship 1791726Authorship 1811396Authorship 1830804Authorship 1873584Authorship 1885997Authorship 1906249Authorship 1920054Authorship 19218610Authorship 1936852Authorship 1942473Authorship 1942486Authorship 19508413Authorship 1952316Authorship 1955682Authorship 19573438522345Li S, Sun G, Budde RJHybridomaProduction and characterization of monoclonal antibodies against the recombinant p50csk protein tyrosine kinase: a tool for signal transduction research. Hybridoma. 1995 Aug; 14(4):341-6.Hybridoma1995-08-01T00:00:001995Production and characterization of monoclonal antibodies against the recombinant p50csk protein tyrosine kinase: a tool for signal transduction research.8918474Carter MS, Li S, Wilkinson MFThe EMBO journalA splicing-dependent regulatory mechanism that detects translation signals. EMBO J. 1996 Nov 01; 15(21):5965-75.EMBO J1996-11-01T00:00:001996A splicing-dependent regulatory mechanism that detects translation signals.11313829Li S, MacLaughlin FC, Fewell JG, Gondo M, Wang J, Nicol F, Dean DA, Smith LCGene therapyMuscle-specific enhancement of gene expression by incorporation of SV40 enhancer in the expression plasmid. Gene Ther. 2001 Mar; 8(6):494-7.Gene Ther2001-03-01T00:00:002001Muscle-specific enhancement of gene expression by incorporation of SV40 enhancer in the expression plasmid.15006601Li S, Xia X, Mellieon FM, Liu J, Steele SMolecular therapy : the journal of the American Society of Gene TherapyCandidate genes associated with tumor regression mediated by intratumoral IL-12 electroporation gene therapy. Mol Ther. 2004 Mar; 9(3):347-54.Mol Ther2004-03-01T00:00:002004Candidate genes associated with tumor regression mediated by intratumoral IL-12 electroporation gene therapy.16823840Liu J, Xia X, Torrero M, Barrett R, Shillitoe EJ, Li SInternational journal of cancerThe mechanism of exogenous B7.1-enhanced IL-12-mediated complete regression of tumors by a single electroporation delivery. Int J Cancer. 2006 Nov 01; 119(9):2113-8.Int J Cancer2006-11-01T00:00:002006The mechanism of exogenous B7.1-enhanced IL-12-mediated complete regression of tumors by a single electroporation delivery.18388923Craig R, Cutrera J, Zhu S, Xia X, Lee YH, Li SMolecular therapy : the journal of the American Society of Gene TherapyAdministering plasmid DNA encoding tumor vessel-anchored IFN-alpha for localizing gene product within or into tumors. Mol Ther. 2008 May; 16(5):901-6.Mol Ther2008-03-18T00:00:002008Administering plasmid DNA encoding tumor vessel-anchored IFN-alpha for localizing gene product within or into tumors.19713998Cutrera J, Dibra D, Xia X, Li SCancer gene therapyEnhancement of reporter gene detection sensitivity by insertion of specific mini-peptide-coding sequences. Cancer Gene Ther. 2010 Feb; 17(2):131-40.Cancer Gene Ther2009-08-28T00:00:002009Enhancement of reporter gene detection sensitivity by insertion of specific mini-peptide-coding sequences.21559505Dibra D, Cutrera J, Xia X, Li SPloS oneWSX1 expression in tumors induces immune tolerance via suppression of effector immune cells. PLoS One. 2011 Apr 29; 6(4):e19072.PLoS One2011-04-29T00:00:002011WSX1 expression in tumors induces immune tolerance via suppression of effector immune cells.21853100Hu J, Liu X, Hughes D, Esteva FJ, Liu B, Chandra J, Li SPloS oneHerceptin conjugates linked by EDC boost direct tumor cell death via programmed tumor cell necrosis. PLoS One. 2011; 6(8):e23270.PLoS One2011-08-10T00:00:002011Herceptin conjugates linked by EDC boost direct tumor cell death via programmed tumor cell necrosis.23111105Cutrera J, Johnson B, Ellis L, Li SCancer lettersIntraosseous inoculation of tumor cells into bone marrow promotes distant metastatic tumor development: A novel tool for mechanistic and therapeutic studies. Cancer Lett. 2013 Feb 01; 329(1):68-73.Cancer Lett2012-10-27T00:00:002012Intraosseous inoculation of tumor cells into bone marrow promotes distant metastatic tumor development: A novel tool for mechanistic and therapeutic studies.23597659Mitra A, Mishra L, Li STrends in biotechnologyTechnologies for deriving primary tumor cells for use in personalized cancer therapy. Trends Biotechnol. 2013 Jun; 31(6):347-54.Trends Biotechnol2013-04-16T00:00:002013Technologies for deriving primary tumor cells for use in personalized cancer therapy.23936456Irwin ME, Nelson LD, Santiago-O'Farrill JM, Knouse PD, Miller CP, Palla SL, Siwak DR, Mills GB, Estrov Z, Li S, Kornblau SM, Hughes DP, Chandra JPloS oneSmall molecule ErbB inhibitors decrease proliferative signaling and promote apoptosis in philadelphia chromosome-positive acute lymphoblastic leukemia. PLoS One. 2013; 8(8):e70608.PLoS One2013-08-01T00:00:002013Small molecule ErbB inhibitors decrease proliferative signaling and promote apoptosis in philadelphia chromosome-positive acute lymphoblastic leukemia.24330710Dibra D, Li SCell communication and signaling : CCSThe cell-to-cell coordination between activated T cells and CpG-stimulated macrophages synergistically induce elevated levels of IL-10 via NF-?B1, STAT3, and CD40/CD154. Cell Commun Signal. 2013 Dec 13; 11:95.Cell Commun Signal2013-12-13T00:00:002013The cell-to-cell coordination between activated T cells and CpG-stimulated macrophages synergistically induce elevated levels of IL-10 via NF-?B1, STAT3, and CD40/CD154.24448245Satelli A, Mitra A, Cutrera JJ, Devarie M, Xia X, Ingram DR, Dibra D, Somaiah N, Torres KE, Ravi V, Ludwig JA, Kleinerman ES, Li SCancer researchUniversal marker and detection tool for human sarcoma circulating tumor cells. Cancer Res. 2014 Mar 15; 74(6):1645-50.Cancer Res2014-01-21T00:00:002014Universal marker and detection tool for human sarcoma circulating tumor cells.24510810Hu J, Cutrera J, Li SMethods in molecular biology (Clifton, N.J.)The impact of non-electrical factors on electrical gene transfer. Methods Mol Biol. 2014; 1121:47-54.Methods Mol Biol2014-01-01T00:00:002014The impact of non-electrical factors on electrical gene transfer.24510827Cutrera J, King G, Jones P, Gumpel E, Xia X, Li SMethods in molecular biology (Clifton, N.J.)Managing local swelling following intratumoral electro-chemo-gene therapy. Methods Mol Biol. 2014; 1121:233-9.Methods Mol Biol2014-01-01T00:00:002014Managing local swelling following intratumoral electro-chemo-gene therapy.24565056Hu J, Zhu S, Xia X, Zhang L, Kleinerman ES, Li SMolecular cancerCD8+T cell-specific induction of NKG2D receptor by doxorubicin plus interleukin-12 and its contribution to CD8+T cell accumulation in tumors. Mol Cancer. 2014 Feb 24; 13:34.Mol Cancer2014-02-24T00:00:002014CD8+T cell-specific induction of NKG2D receptor by doxorubicin plus interleukin-12 and its contribution to CD8+T cell accumulation in tumors.24709009Wang X, Li SBiochimica et biophysica actaProtein mislocalization: mechanisms, functions and clinical applications in cancer. Biochim Biophys Acta. 2014 Aug; 1846(1):13-25.Biochim Biophys Acta2014-04-04T00:00:002014Protein mislocalization: mechanisms, functions and clinical applications in cancer.Experimental TherapeuticsGeneticsGenitourinary Medical OncologyGynecological Oncology & Reproductive MedicineHead & Neck SurgeryMolecular & Cellular OncologyPediatricsSurgical OncologySystems BiologyMD AndersonMIEN-CHIEHUNGMIEN-CHIE HUNG8427HUNG, MIEN-CHIEProfessorANJANABHARDWAJANJANA BHARDWAJ9092BHARDWAJ, ANJANAAssistant ProfessorEHAB YHANNAEHAB Y HANNA9145HANNA, EHAB YProfessorTIMOTHYTHOMPSONTIMOTHY THOMPSON9463THOMPSON, TIMOTHYProfessor4.618890.00353882401research areas3.202810.027647122coauthor of57.171714.775260similar to11103selected publicationsGORDON BMILLSGORDON B MILLS8620MILLS, GORDON BProfessorEUGENIE SKLEINERMANEUGENIE S KLEINERMAN8489KLEINERMAN, EUGENIE SProfessorGEORGE ACALINGEORGE A CALIN9408CALIN, GEORGE AProfessorLEE MELLISLEE M ELLIS8478ELLIS, LEE MProfessorANIL KSOODANIL K SOOD9048SOOD, ANIL KProfessorAuthorship 2152761Authorship 2158501Authorship 2160311Authorship 2179191Authorship 2183763Authorship 2189653Authorship 2189751Authorship 2222201Authorship 2268575Authorship 2268582Authorship 2272751Authorship 2315506Authorship 2342502Authorship 2350985Authorship 23532038979366Li S, Ke S, Budde RJCell biology internationalThe C-terminal Src kinase (Csk) is widely expressed, active in HT-29 cells that contain activated Src, and its expression is downregulated in butyrate-treated SW620 cells. Cell Biol Int. 1996 Nov; 20(11):723-9.Cell Biol Int1996-11-01T00:00:001996The C-terminal Src kinase (Csk) is widely expressed, active in HT-29 cells that contain activated Src, and its expression is downregulated in butyrate-treated SW620 cells.9091590Li S, Leonard D, Wilkinson MFThe Journal of experimental medicineT cell receptor (TCR) mini-gene mRNA expression regulated by nonsense codons: a nuclear-associated translation-like mechanism. J Exp Med. 1997 Mar 17; 185(6):985-92.J Exp Med1997-03-17T00:00:001997T cell receptor (TCR) mini-gene mRNA expression regulated by nonsense codons: a nuclear-associated translation-like mechanism.9343667Li S, Wilkinson MFBioTechniquesSite-directed mutagenesis: a two-step method using PCR and DpnI. Biotechniques. 1997 Oct; 23(4):588-90.Biotechniques1997-10-01T00:00:001997Site-directed mutagenesis: a two-step method using PCR and DpnI.9491995Li S, Wilkinson MFImmunityNonsense surveillance in lymphocytes? Immunity. 1998 Feb; 8(2):135-41.Immunity1998-02-01T00:00:001998Nonsense surveillance in lymphocytes?11511358M?hlemann O, Mock-Casagrande CS, Wang J, Li S, Cust?dio N, Carmo-Fonseca M, Wilkinson MF, Moore MJMolecular cellPrecursor RNAs harboring nonsense codons accumulate near the site of transcription. Mol Cell. 2001 Jul; 8(1):33-43.Mol Cell2001-07-01T00:00:002001Precursor RNAs harboring nonsense codons accumulate near the site of transcription.11926910Dornhoffer JL, Danner C, Li SArchives of otolaryngology--head & neck surgeryNatriuretic peptide receptors in the human endolymphatic sac. Arch Otolaryngol Head Neck Surg. 2002 Apr; 128(4):379-83.Arch Otolaryngol Head Neck Surg2002-04-01T00:00:002002Natriuretic peptide receptors in the human endolymphatic sac.11960315Li S, Xia X, Zhang X, Suen JGene therapyRegression of tumors by IFN-alpha electroporation gene therapy and analysis of the responsible genes by cDNA array. Gene Ther. 2002 Mar; 9(6):390-7.Gene Ther2002-03-01T00:00:002002Regression of tumors by IFN-alpha electroporation gene therapy and analysis of the responsible genes by cDNA array.15585412Li S, Wilkinson M, Xia X, David M, Xu L, Purkel-Sutton A, Bhardwaj AMolecular therapy : the journal of the American Society of Gene TherapyInduction of IFN-regulated factors and antitumoral surveillance by transfected placebo plasmid DNA. Mol Ther. 2005 Jan; 11(1):112-9.Mol Ther2005-01-01T00:00:002005Induction of IFN-regulated factors and antitumoral surveillance by transfected placebo plasmid DNA.18370210Cutrera J, Torrero M, Shiomitsu K, Mauldin N, Li SMethods in molecular biology (Clifton, N.J.)Intratumoral bleomycin and IL-12 electrochemogenetherapy for treating head and neck tumors in dogs. Methods Mol Biol. 2008; 423:319-25.Methods Mol Biol2008-01-01T00:00:002008Intratumoral bleomycin and IL-12 electrochemogenetherapy for treating head and neck tumors in dogs.18370212Torrero M, Li SMethods in molecular biology (Clifton, N.J.)Treatment of SCCVII tumors with systemic chemotherapy and Interleukin-12 gene therapy combination. Methods Mol Biol. 2008; 423:339-49.Methods Mol Biol2008-01-01T00:00:002008Treatment of SCCVII tumors with systemic chemotherapy and Interleukin-12 gene therapy combination.18453074Li SMethods in molecular biology (Clifton, N.J.)Electroporation gene therapy. Preface. Methods Mol Biol. 2008; 423:v-vii.Methods Mol Biol2008-01-01T00:00:002008Electroporation gene therapy. Preface.22512891Flanagan M, Gimble JM, Yu G, Xia X, Bunnell BA, Li SBiological procedures onlineCompetitive DNA transfection formulation via electroporation for human adipose stem cells and mesenchymal stem cells. Biol Proced Online. 2012 Apr 18; 14(1):7.Biol Proced Online2012-04-18T00:00:002012Competitive DNA transfection formulation via electroporation for human adipose stem cells and mesenchymal stem cells.24369443Cutrera J, Dibra D, Satelli A, Xia X, Li SMediators of inflammationIntricacies for posttranslational tumor-targeted cytokine gene therapy. Mediators Inflamm. 2013; 2013:378971.Mediators Inflamm2013-11-27T00:00:002013Intricacies for posttranslational tumor-targeted cytokine gene therapy.24510811Hu J, Li SMethods in molecular biology (Clifton, N.J.)Electroporation formulation for cell therapy. Methods Mol Biol. 2014; 1121:55-60.Methods Mol Biol2014-01-01T00:00:002014Electroporation formulation for cell therapy.24821201Dibra D, Mishra L, Li SBiochimica et biophysica actaMolecular mechanisms of oncogene-induced inflammation and inflammation-sustained oncogene activation in gastrointestinal tumors: an under-appreciated symbiotic relationship. Biochim Biophys Acta. 2014 Aug; 1846(1):152-60.Biochim Biophys Acta2014-05-09T00:00:002014Molecular mechanisms of oncogene-induced inflammation and inflammation-sustained oncogene activation in gastrointestinal tumors: an under-appreciated symbiotic relationship.Authorship 2382794Authorship 2441231Authorship 2441694Authorship 2447163Authorship 2447184Authorship 2464301Authorship 2488613Authorship 2499544Authorship 2525202Authorship 2525225Authorship 2525661Authorship 2527897Authorship 2552482Authorship 2558696Authorship 2559191Authorship 2559628Authorship 2560102Authorship 2561815Authorship 2569876Authorship 2588835Authorship 26040277499432Carter MS, Doskow J, Morris P, Li S, Nhim RP, Sandstedt S, Wilkinson MFThe Journal of biological chemistryA regulatory mechanism that detects premature nonsense codons in T-cell receptor transcripts in vivo is reversed by protein synthesis inhibitors in vitro. J Biol Chem. 1995 Dec 01; 270(48):28995-9003.J Biol Chem1995-12-01T00:00:001995A regulatory mechanism that detects premature nonsense codons in T-cell receptor transcripts in vivo is reversed by protein synthesis inhibitors in vitro.12011227Li S, Zhang X, Xia XJournal of the National Cancer InstituteRegression of tumor growth and induction of long-term antitumor memory by interleukin 12 electro-gene therapy. J Natl Cancer Inst. 2002 May 15; 94(10):762-8.J Natl Cancer Inst2002-05-15T00:00:002002Regression of tumor growth and induction of long-term antitumor memory by interleukin 12 electro-gene therapy.12097281Pumphrey CY, Theus AM, Li S, Parrish RS, Sanderson RDCancer researchNeoglycans, carbodiimide-modified glycosaminoglycans: a new class of anticancer agents that inhibit cancer cell proliferation and induce apoptosis. Cancer Res. 2002 Jul 01; 62(13):3722-8.Cancer Res2002-07-01T00:00:002002Neoglycans, carbodiimide-modified glycosaminoglycans: a new class of anticancer agents that inhibit cancer cell proliferation and induce apoptosis.12098701Wang J, Hamilton JI, Carter MS, Li S, Wilkinson MFScience (New York, N.Y.)Alternatively spliced TCR mRNA induced by disruption of reading frame. Science. 2002 Jul 05; 297(5578):108-10.Science2002-07-05T00:00:002002Alternatively spliced TCR mRNA induced by disruption of reading frame.12450181Dornhoffer JL, Danner C, Zhou L, Li SThe Annals of otology, rhinology, and laryngologyAtrial natriuretic peptide receptor upregulation in the rat inner ear. Ann Otol Rhinol Laryngol. 2002 Nov; 111(11):1040-4.Ann Otol Rhinol Laryngol2002-11-01T00:00:002002Atrial natriuretic peptide receptor upregulation in the rat inner ear.15384944Li SCurrent gene therapyElectroporation gene therapy: new developments in vivo and in vitro. Curr Gene Ther. 2004 Sep; 4(3):309-16.Curr Gene Ther2004-09-01T00:00:002004Electroporation gene therapy: new developments in vivo and in vitro.16397050Torrero MN, Henk WG, Li SClinical cancer research : an official journal of the American Association for Cancer ResearchRegression of high-grade malignancy in mice by bleomycin and interleukin-12 electrochemogenetherapy. Clin Cancer Res. 2006 Jan 01; 12(1):257-63.Clin Cancer Res2006-01-01T00:00:002006Regression of high-grade malignancy in mice by bleomycin and interleukin-12 electrochemogenetherapy.17634555Zhu S, Waguespack M, Barker SA, Li SClinical cancer research : an official journal of the American Association for Cancer ResearchDoxorubicin directs the accumulation of interleukin-12 induced IFN gamma into tumors for enhancing STAT1 dependent antitumor effect. Clin Cancer Res. 2007 Jul 15; 13(14):4252-60.Clin Cancer Res2007-07-15T00:00:002007Doxorubicin directs the accumulation of interleukin-12 induced IFN gamma into tumors for enhancing STAT1 dependent antitumor effect.18370209Li SMethods in molecular biology (Clifton, N.J.)Delivery of DNA into tumors. Methods Mol Biol. 2008; 423:311-8.Methods Mol Biol2008-01-01T00:00:002008Delivery of DNA into tumors.19545229Reed SD, Li SCurrent gene therapyElectroporation advances in large animals. Curr Gene Ther. 2009 Aug; 9(4):316-26.Curr Gene Ther2009-08-01T00:00:002009Electroporation advances in large animals.19549909Dibra D, Cutrera JJ, Xia X, Birkenbach MP, Li SCancer researchExpression of WSX1 in tumors sensitizes IL-27 signaling-independent natural killer cell surveillance. Cancer Res. 2009 Jul 01; 69(13):5505-13.Cancer Res2009-06-23T00:00:002009Expression of WSX1 in tumors sensitizes IL-27 signaling-independent natural killer cell surveillance.20150931Reed SD, Fulmer A, Buckholz J, Zhang B, Cutrera J, Shiomitsu K, Li SCancer gene therapyBleomycin/interleukin-12 electrochemogene therapy for treating naturally occurring spontaneous neoplasms in dogs. Cancer Gene Ther. 2010 Jul; 17(7):457-64.Cancer Gene Ther2010-02-12T00:00:002010Bleomycin/interleukin-12 electrochemogene therapy for treating naturally occurring spontaneous neoplasms in dogs.21233859Reed SD, Li SCancer gene therapyPre-clinical toxicity assessment of tumor-targeted interleukin-12 low-intensity electrogenetherapy. Cancer Gene Ther. 2011 Apr; 18(4):265-74.Cancer Gene Ther2011-01-14T00:00:002011Pre-clinical toxicity assessment of tumor-targeted interleukin-12 low-intensity electrogenetherapy.21369533Li SBiological procedures onlineBiological Procedures Online now publishing with BioMed Central. Biol Proced Online. 2011 Jan 31; 13:2.Biol Proced Online2011-01-31T00:00:002011Biological Procedures Online now publishing with BioMed Central.21386825Cutrera J, Dibra D, Xia X, Hasan A, Reed S, Li SMolecular therapy : the journal of the American Society of Gene TherapyDiscovery of a linear peptide for improving tumor targeting of gene products and treatment of distal tumors by IL-12 gene therapy. Mol Ther. 2011 08; 19(8):1468-77.Mol Ther2011-03-08T00:00:002011Discovery of a linear peptide for improving tumor targeting of gene products and treatment of distal tumors by IL-12 gene therapy.21637948Satelli A, Li SCellular and molecular life sciences : CMLSVimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci. 2011 Sep; 68(18):3033-46.Cell Mol Life Sci2011-06-03T00:00:002011Vimentin in cancer and its potential as a molecular target for cancer therapy.21660061Flanagan M, Gimble JM, Yu G, Wu X, Xia X, Hu J, Yao S, Li SCancer gene therapyCompetitive electroporation formulation for cell therapy. Cancer Gene Ther. 2011 Aug; 18(8):579-86.Cancer Gene Ther2011-06-10T00:00:002011Competitive electroporation formulation for cell therapy.21801027Zolochevska O, Xia X, Williams BJ, Ramsay A, Li S, Figueiredo MLHuman gene therapySonoporation delivery of interleukin-27 gene therapy efficiently reduces prostate tumor cell growth in vivo. Hum Gene Ther. 2011 Dec; 22(12):1537-50.Hum Gene Ther2011-09-01T00:00:002011Sonoporation delivery of interleukin-27 gene therapy efficiently reduces prostate tumor cell growth in vivo.22105582Dibra D, Cutrera J, Xia X, Kallakury B, Mishra L, Li SHepatology (Baltimore, Md.)Interleukin-30: a novel antiinflammatory cytokine candidate for prevention and treatment of inflammatory cytokine-induced liver injury. Hepatology. 2012 Apr; 55(4):1204-14.Hepatology2012-03-01T00:00:002012Interleukin-30: a novel antiinflammatory cytokine candidate for prevention and treatment of inflammatory cytokine-induced liver injury.23225163Liu Z, Liu JQ, Talebian F, Wu LC, Li S, Bai XFEuropean journal of immunologyIL-27 enhances the survival of tumor antigen-specific CD8+ T cells and programs them into IL-10-producing, memory precursor-like effector cells. Eur J Immunol. 2013 Feb; 43(2):468-79.Eur J Immunol2013-01-15T00:00:002013IL-27 enhances the survival of tumor antigen-specific CD8+ T cells and programs them into IL-10-producing, memory precursor-like effector cells.23907698Fang RH, Hu CM, Chen KN, Luk BT, Carpenter CW, Gao W, Li S, Zhang DE, Lu W, Zhang LNanoscaleLipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles. Nanoscale. 2013 Oct 07; 5(19):8884-8.Nanoscale2013-08-01T00:00:002013Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles.25971300Yan J, Kong LY, Hu J, Gabrusiewicz K, Dibra D, Xia X, Heimberger AB, Li SJournal of the National Cancer InstituteFGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas. J Natl Cancer Inst. 2015 Aug; 107(8).J Natl Cancer Inst2015-05-13T00:00:002015FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas.Authorship 2639473Authorship 2657141Authorship 2665461Authorship 2674225Authorship 2679012Authorship 2689723Authorship 2692707Authorship 2694061Authorship 27013038663309Maiti S, Doskow J, Li S, Nhim RP, Lindsey JS, Wilkinson MFThe Journal of biological chemistryThe Pem homeobox gene. Androgen-dependent and -independent promoters and tissue-specific alternative RNA splicing. J Biol Chem. 1996 Jul 19; 271(29):17536-46.J Biol Chem1996-07-19T00:00:001996The Pem homeobox gene. Androgen-dependent and -independent promoters and tissue-specific alternative RNA splicing.12108971Li S, Benninger MCurrent gene therapyApplications of muscle electroporation gene therapy. Curr Gene Ther. 2002 Feb; 2(1):101-5.Curr Gene Ther2002-02-01T00:00:002002Applications of muscle electroporation gene therapy.15953768Li S, Zhang L, Torrero M, Cannon M, Barret RMolecular therapy : the journal of the American Society of Gene TherapyAdministration route- and immune cell activation-dependent tumor eradication by IL12 electrotransfer. Mol Ther. 2005 Nov; 12(5):942-9.Mol Ther2005-06-13T00:00:002005Administration route- and immune cell activation-dependent tumor eradication by IL12 electrotransfer.16618773Torrero MN, Xia X, Henk W, Yu S, Li SCancer researchStat1 deficiency in the host enhances interleukin-12-mediated tumor regression. Cancer Res. 2006 Apr 15; 66(8):4461-7.Cancer Res2006-04-15T00:00:002006Stat1 deficiency in the host enhances interleukin-12-mediated tumor regression.18370211Zhu S, Li SMethods in molecular biology (Clifton, N.J.)Systemic IL-12 gene therapy for treating malignancy via intramuscular electroporation. Methods Mol Biol. 2008; 423:327-37.Methods Mol Biol2008-01-01T00:00:002008Systemic IL-12 gene therapy for treating malignancy via intramuscular electroporation.19728006Li SBiological procedures onlineThe possible cellular mechanism for extending lifespan of mice with rapamycin. Biol Proced Online. 2009 Sep 01; 11:1-2.Biol Proced Online2009-09-01T00:00:002009The possible cellular mechanism for extending lifespan of mice with rapamycin.20139275Zhu S, Lee DA, Li SJournal of immunology (Baltimore, Md. : 1950)IL-12 and IL-27 sequential gene therapy via intramuscular electroporation delivery for eliminating distal aggressive tumors. J Immunol. 2010 Mar 01; 184(5):2348-54.J Immunol2010-02-05T00:00:002010IL-12 and IL-27 sequential gene therapy via intramuscular electroporation delivery for eliminating distal aggressive tumors.20414325Reed SD, Fulmer A, Buckholz J, Zhang B, Cutrera J, Shiomitsu K, Li SCancer gene therapyBleomycin/interleukin-12 electrochemogenetherapy for treating naturally occurring spontaneous neoplasms in dogs. Cancer Gene Ther. 2010 Aug; 17(8):571-8.Cancer Gene Ther2010-04-23T00:00:002010Bleomycin/interleukin-12 electrochemogenetherapy for treating naturally occurring spontaneous neoplasms in dogs.22407920Dibra D, Cutrera JJ, Li SJournal of immunology (Baltimore, Md. : 1950)Coordination between TLR9 signaling in macrophages and CD3 signaling in T cells induces robust expression of IL-30. J Immunol. 2012 Apr 15; 188(8):3709-15.J Immunol2012-03-09T00:00:002012Coordination between TLR9 signaling in macrophages and CD3 signaling in T cells induces robust expression of IL-30.Authorship 2730612Authorship 273554616842125Craig R, Li SMini reviews in medicinal chemistryFunction and molecular mechanism of tumor-targeted peptides for delivering therapeutic genes and chemical drugs. Mini Rev Med Chem. 2006 Jul; 6(7):757-64.Mini Rev Med Chem2006-07-01T00:00:002006Function and molecular mechanism of tumor-targeted peptides for delivering therapeutic genes and chemical drugs.19178679Shiomitsu K, Sajo E, Xia X, Hunley DW, Mauldin GE, Li S, Mauldin GNVeterinary and comparative oncologyRadiosensitivity of canine osteosarcoma cells transfected with wild-type p53 in vitro. Vet Comp Oncol. 2008 Sep; 6(3):193-200.Vet Comp Oncol2008-09-01T00:00:002008Radiosensitivity of canine osteosarcoma cells transfected with wild-type p53 in vitro.25351459Mitra A, Satelli A, Yan J, Xueqing X, Gagea M, Hunter CA, Mishra L, Li SHepatology (Baltimore, Md.)IL-30 (IL27p28) attenuates liver fibrosis through inducing NKG2D-rae1 interaction between NKT and activated hepatic stellate cells in mice. Hepatology. 2014 Dec; 60(6):2027-39.Hepatology2014-10-28T00:00:002014IL-30 (IL27p28) attenuates liver fibrosis through inducing NKG2D-rae1 interaction between NKT and activated hepatic stellate cells in mice.25487874Mitra A, Satelli A, Xia X, Cutrera J, Mishra L, Li SInternational journal of cancerCell-surface Vimentin: A mislocalized protein for isolating csVimentin(+) CD133(-) novel stem-like hepatocellular carcinoma cells expressing EMT markers. Int J Cancer. 2015 Jul 15; 137(2):491-6.Int J Cancer2014-12-18T00:00:002014Cell-surface Vimentin: A mislocalized protein for isolating csVimentin(+) CD133(-) novel stem-like hepatocellular carcinoma cells expressing EMT markers.25516888Satelli A, Mitra A, Brownlee Z, Xia X, Bellister S, Overman MJ, Kopetz S, Ellis LM, Meng QH, Li SClinical cancer research : an official journal of the American Association for Cancer ResearchEpithelial-mesenchymal transitioned circulating tumor cells capture for detecting tumor progression. Clin Cancer Res. 2015 Feb 15; 21(4):899-906.Clin Cancer Res2014-12-16T00:00:002014Epithelial-mesenchymal transitioned circulating tumor cells capture for detecting tumor progression.11332985Hanna E, Zhang X, Woodlis J, Breau R, Suen J, Li SCancer gene therapyIntramuscular electroporation delivery of IL-12 gene for treatment of squamous cell carcinoma located at distant site. Cancer Gene Ther. 2001 Mar; 8(3):151-7.Cancer Gene Ther2001-03-01T00:00:002001Intramuscular electroporation delivery of IL-12 gene for treatment of squamous cell carcinoma located at distant site.11289099Hanna E, Shrieve DC, Ratanatharathorn V, Xia X, Breau R, Suen J, Li SCancer researchA novel alternative approach for prediction of radiation response of squamous cell carcinoma of head and neck. Cancer Res. 2001 Mar 15; 61(6):2376-80.Cancer Res2001-03-15T00:00:002001A novel alternative approach for prediction of radiation response of squamous cell carcinoma of head and neck.74Professor10Assistant Professor54Instructor11313817Li S, Zhang X, Xia X, Zhou L, Breau R, Suen J, Hanna EGene therapyIntramuscular electroporation delivery of IFN-alpha gene therapy for inhibition of tumor growth located at a distant site. Gene Ther. 2001 Mar; 8(5):400-7.Gene Ther2001-03-01T00:00:002001Intramuscular electroporation delivery of IFN-alpha gene therapy for inhibition of tumor growth located at a distant site.Breast Surgical OncologyDENADADIBRADENADA DIBRA11807DIBRA, DENADAInstructor14997212Li S, Hanna E, Breau R, Ratanatharathorn V, Xia X, Suen JBritish journal of cancerPreferential expression of hPGFS in primary SCCHN and tumour cell lines derived from respiratory and digestive organs. Br J Cancer. 2004 Mar 08; 90(5):1093-9.Br J Cancer2004-03-08T00:00:002004Preferential expression of hPGFS in primary SCCHN and tumour cell lines derived from respiratory and digestive organs.Authorship 3743848Authorship 37438910Authorship 3744236Authorship 3744248Authorship 842054Authorship 842594Authorship 843646Authorship 844471Authorship 845119Authorship 845471Authorship 847047Authorship 848140Authorship 851243Authorship 851317Authorship 851977Authorship 852099Authorship 852133Authorship 853982Authorship 854423Authorship 855122Authorship 855175Authorship 855185Authorship 856392Authorship 860374Authorship 861763Authorship 861996Authorship 862309Authorship 862452Authorship 864239Authorship 865688Authorship 867056Authorship 868157OncotargetEMT, CTCs and CSCs in tumor relapse and drug-resistance. Oncotarget. 6:10697-10711.EMT, CTCs and CSCs in tumor relapse and drug-resistanceJournal of HepatologyCorrigendum to "Interleukin-30 (IL27p28) alleviates experimental sepsis by modulating cytokine profile in NKT cells". Journal of Hepatology. Corrigendum to "Interleukin-30 (IL27p28) alleviates experimental sepsis by modulating cytokine profile in NKT cells"International Reviews of ImmunologyThe Duality of Fgl2 - Secreted Immune Checkpoint Regulator Versus Membrane-Associated Procoagulant. International Reviews of Immunology. The Duality of Fgl2 - Secreted Immune Checkpoint Regulator Versus Membrane-Associated ProcoagulantHepatologyMutant p53 in concert with an interleukin-27 receptor alpha deficiency causes spontaneous liver inflammation, fibrosis, and steatosis in mice. Hepatology. Mutant p53 in concert with an interleukin-27 receptor alpha deficiency causes spontaneous liver inflammation, fibrosis, and steatosis in miceJournal of CancerPotential function of exogenous vimentin on the activation of Wnt signaling pathway in cancer cells. Journal of Cancer. 7:1824-1832.Potential function of exogenous vimentin on the activation of Wnt signaling pathway in cancer cellsScientific ReportsPotential role of nuclear PD-L1 expression in cell-surface vimentin positive circulating tumor cells as a prognostic marker in cancer patients. Scientific Reports. 6.Potential role of nuclear PD-L1 expression in cell-surface vimentin positive circulating tumor cells as a prognostic marker in cancer patientsClinical Cancer ResearchLack of immunomodulatory interleukin-27 enhances oncogenic properties of mutant p53 in vivo. Clinical Cancer Research. 22:3876-3883.Lack of immunomodulatory interleukin-27 enhances oncogenic properties of mutant p53 in vivoPassive and active tumor homing cytokine therapy. 97-113.Passive and active tumor homing cytokine therapyMolecular TherapyErratum. Molecular Therapy. 20:1076.ErratumTargeted cancer immune therapy. Targeted cancer immune therapyRole of IL12 family in regulation of antitumor immune response. 3-18.Role of IL12 family in regulation of antitumor immune responsePostharvest Biology and TechnologyEffects of ethephon on the respiration and ethylene evolution of sweet cherry (Prunus avium L.) fruit at different development stages. Postharvest Biology and Technology. 4:235-243.Effects of ethephon on the respiration and ethylene evolution of sweet cherry (Prunus avium L.) fruit at different development stagesOncotargetIL27 controls skin tumorigenesis via accumulation of ETAR-positive CD11b cells in the pre-malignant skin. Oncotarget. 7:77138-77151.IL27 controls skin tumorigenesis via accumulation of ETAR-positive CD11b cells in the pre-malignant skinJournal of Clinical InvestigationTGF-β/β2-spectrin/CTCF-regulated tumor suppression in human stem cell disorder Beckwith-Wiedemann syndrome. Journal of Clinical Investigation. 126:527-542.TGF-β/β2-spectrin/CTCF-regulated tumor suppression in human stem cell disorder Beckwith-Wiedemann syndromeJournal of Agricultural and Food ChemistryPartial purification and characterization of β-D-galactosidase from sweet cherry, a nonclimacteric fruit. Journal of Agricultural and Food Chemistry. 42:2177-2182.Partial purification and characterization of β-D-galactosidase from sweet cherry, a nonclimacteric fruitPLoS OneMutational profiles reveal an aberrant TGF-β-CEA regulated pathway in colon adenomas. PLoS One. 11.Mutational profiles reveal an aberrant TGF-β-CEA regulated pathway in colon adenomasOncotargetDiscovery of cell surface vimentin targeting mAb for direct disruption of GBM tumor initiating cells. Oncotarget. 7:72021-72032.Discovery of cell surface vimentin targeting mAb for direct disruption of GBM tumor initiating cellsDrugs of TodayIL-12-based therapy of malignancies. Drugs of Today. 37:629-637.IL-12-based therapy of malignanciesHepatologyReply. Hepatology. 56:2425.ReplyBiological Procedures OnlineErratum. Biological Procedures Online. 18.ErratumUnknown JournalPreface. Unknown Journal. PrefaceOncoImmunologyRegulation of NKG2D<sup>+</sup>CD8<sup>+</sup> T-cell-mediated antitumor immune surveillance. OncoImmunology. 5.Regulation of NKG2D<sup>+</sup>CD8<sup>+</sup> T-cell-mediated antitumor immune surveillanceScientific ReportsVitamin D Deficiency Promotes Liver Tumor Growth in Transforming Growth Factor-β/Smad3-Deficient Mice Through Wnt and Toll-like Receptor 7 Pathway Modulation. Scientific Reports. 6.Vitamin D Deficiency Promotes Liver Tumor Growth in Transforming Growth Factor-β/Smad3-Deficient Mice Through Wnt and Toll-like Receptor 7 Pathway ModulationTheranosticsSafe and immunocompatible nanocarriers cloaked in RBC membranes for drug delivery to treat solid tumors. Theranostics. 6:1004-1011.Safe and immunocompatible nanocarriers cloaked in RBC membranes for drug delivery to treat solid tumorsBiological Procedures OnlineGeneration of a monoclonal antibody against the glycosylphosphatidylinositol-linked protein Rae-1 using genetically engineered tumor cells. Biological Procedures Online. 16.Generation of a monoclonal antibody against the glycosylphosphatidylinositol-linked protein Rae-1 using genetically engineered tumor cellsCancer Gene TherapyErratum. Cancer Gene Therapy. 17:826.ErratumJournal of HepatologyInterleukin-30 (IL27p28) alleviates experimental sepsis by modulating cytokine profile in NKT cells. Journal of Hepatology. Interleukin-30 (IL27p28) alleviates experimental sepsis by modulating cytokine profile in NKT cellsFASEB JournalT cell receptor mRNA regulation. FASEB Journal. 10.T cell receptor mRNA regulation10637452Li S, MacLaughlin FC, Fewell JG, Li Y, Mehta V, French MF, Nordstrom JL, Coleman M, Belagali NS, Schwartz RJ, Smith LCGene therapyIncreased level and duration of expression in muscle by co-expression of a transactivator using plasmid systems. Gene Ther. 1999 Dec; 6(12):2005-11.Gene Ther1999-12-01T00:00:001999Increased level and duration of expression in muscle by co-expression of a transactivator using plasmid systems.22710573Majumdar A, Curley SA, Wu X, Brown P, Hwang JP, Shetty K, Yao ZX, He AR, Li S, Katz L, Farci P, Mishra LNature reviews. Gastroenterology & hepatologyHepatic stem cells and transforming growth factor ? in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2012 Sep; 9(9):530-8.Nat Rev Gastroenterol Hepatol2012-06-19T00:00:002012Hepatic stem cells and transforming growth factor ? in hepatocellular carcinoma.D015316Procedures46916050.558776Genetic TherapyD053672Procedures390.987477ElectrochemotherapyD018274Procedures711270.92142ElectroporationD018664Chemicals & Drugs1322530.872405Interleukin-12D018014DevicesProcedures2987150.772868Gene Transfer Techniquestrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessortrue1InstructorInstructor